After having a successful IPO less than a year ago, this biotech innovator had notable insider transactions to close out 2025 ...
What Sionna Therapeutics’ Recent Price Move Means for Investors Sionna Therapeutics (SION) shares recently closed at $39.25, ...
Detailed price information for Tvardi Therapeutics Inc (TVRD-Q) from The Globe and Mail including charting and trades.
According to TipRanks.com, Divan is a 5-star analyst with an average return of 10.7% and a 57.1% success rate. Divan covers the Healthcare sector, focusing on stocks such as Unicycive Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results